Health
Eli Lilly’s weight-loss drug tirzepatide has received approval in China
Eli Lilly said in a social media post Friday its weight-loss drug tirzepatide won approval from Chinese regulators, further boosting competition with Danish rival Novo
Novartis raises profit forecast for second time
Swiss drugmaker Novartis raised its 2024 profit forecast for the second time, boosted by a surge in prescriptions for drugs such as heart failure treatment
Chicken culling raises concerns about the spread of avian influenza
The spread of avian influenza among poultry and dairy farms has raised concerns among some health experts that the process of culling and disposing of
Ardelyx sues US health department over kidney disease drug
Drug maker Ardelyx on Wednesday the company said it has filed a lawsuit against the U.S. Department of Health and Human Services and the Centers
J&J beats Wall Street estimates
Johnson & Johnson beat second-quarter profit and revenue estimates, boosted by strong sales of its drugs, including cancer treatment Darzalex and psoriasis blockbuster Stelara. The
Dutch agency advises against insuring Wegovy
Danish drugmaker Novo Nordisk was disappointed that the Dutch government was advised not to cover its hugely popular weight-loss drug Wegovy in the country’s basic
Bayer considers expanding use of Nubeqa on new data from prostate cancer trial
Bayer said its drug Nubeqa was shown to slow the progression of a certain type of prostate cancer in a late-stage trial, bolstering growth prospects
Novo owner backs Swiss biotech company Asceneuron in $100 million round
Swiss biotech company Asceneuron said Tuesday it has raised $100 million from investors including controlling shareholder Wegovy maker Novo Nordisk to fund clinical development of
U.S. and Colorado investigate new cases of H5N1 avian influenza at a poultry farm
Federal and state investigators in Colorado are investigating an outbreak of H5N1 avian influenza at a poultry farm that has resulted in four confirmed human
Second malaria vaccine launched in Côte d’Ivoire
The world’s second malaria vaccine was launched on Monday as Côte d’Ivoire began a planned vaccination programme using vaccines developed by Oxford University and the